Biomea Fusion (BMEA) Earnings Date & Reports

Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BMEA is expected to report earnings to rise 13.23% to -91 cents per share on April 30

Biomea Fusion BMEA Stock Earnings Reports

Q1'25

Est.

$-0.92

Q4'24

Beat

by $0.10

Q3'24

Beat

by $0.03

Q2'24

Beat

by $0.05

Q1'24

Missed

by $0.10

The last earnings report on March 31 showed earnings per share of -81 cents, beating the estimate of -91 cents. With 667.37K shares outstanding, the current market capitalization sits at 86.42M.

View a ticker or compare two or three

Compare

BMEA